Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients
{{output}}
The sampling of circulating biomarkers provides an opportunity for non-invasive evaluation and monitoring of cancer activity. In modern day practice, this has typically been in the form of circulating tumor DNA (ctDNA) detected in plasma. The field of ctDNA ha... ...
